SYNTA PHARMACEUTICALS CORP's ticker is SNTA and the CUSIP is 87162T206. A total of 76 filers reported holding SYNTA PHARMACEUTICALS CORP in Q4 2015. The put-call ratio across all filers is 1.19 and the average weighting 0.4%.
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| CAXTON CORP | 21,696,894 | $7,637,000 | 32.03% |
| Anson Funds Management LP | 989,204 | $348,000 | 0.11% |
| CAXTON CORP | 62,000 | $22,000 | 0.09% |
| McQueen, Ball & Associates Inc. | 102,742 | $36,000 | 0.03% |
| Sheaff Brock Investment Advisors, LLC | 320,000 | $113,000 | 0.01% |
| Roundview Capital LLC | 21,100 | $7,000 | 0.00% |
| QCM Cayman, Ltd. | 11,197 | $4,000 | 0.00% |
| ZACKS INVESTMENT MANAGEMENT | 193,406 | $68,000 | 0.00% |
| Renaissance Technologies | 2,504,200 | $881,000 | 0.00% |
| Squarepoint Ops LLC | 56,800 | $20,000 | 0.00% |